Back to Search
MILJENKO PILEPICH, M.D.
M.D.
Radiation Oncology Physician
NPI: 1265772982Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
C51283(CA)
Research & Publications (20)
Phase III study of pentosanpolysulfate (PPS) in treatment of gastrointestinal tract sequelae of radiotherapy.
PMID 16601430·Am J Clin Oncol·2006
3-trial
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
PMID 15817329·Int J Radiat Oncol Biol Phys·2005
3-trial
Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.
PMID 19307511·J Clin Oncol·2009
2-rct
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
PMID 19047297·J Clin Oncol·2009
3-trial
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
PMID 18977097·Int J Radiat Oncol Biol Phys·2009
8-other
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.
PMID 18243498·Eur Urol·2008
2-rct
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
PMID 18779620·J Clin Oncol·2008
2-rct
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.
PMID 18455330·Int J Radiat Oncol Biol Phys·2008
3-trial
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.
PMID 18172188·J Clin Oncol·2008
3-trial
Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.
PMID 17881145·Int J Radiat Oncol Biol Phys·2008
3-trial
Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.
PMID 17999404·Cancer·2007
3-trial
Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.
PMID 16427211·Int J Radiat Oncol Biol Phys·2006
2-rct
Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
PMID 16814949·Int J Radiat Oncol Biol Phys·2006
8-other
Influence of number of CAG repeats on local control in the RTOG 86-10 protocol.
PMID 16462497·Am J Clin Oncol·2006
8-other
MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610.
PMID 16007688·Cancer·2005
8-other
Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10).
PMID 16109464·Int J Radiat Oncol Biol Phys·2005
3-trial
Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
PMID 15908657·J Clin Oncol·2005
3-trial
Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
PMID 15681524·J Clin Oncol·2005
3-trial
Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10.
PMID 12947069·J Clin Oncol·2003
8-other
Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.
PMID 12721240·J Clin Oncol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6283 CAVALLERI RD
MALIBU, CA 90265 - Phone
- (310) 597-5147
Quick Facts
- NPI
- 1265772982
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile